News blog


  • BY: Andrew Hore |
  • POSTED: 05/03/2019 |

Neuroscience-focused digital data analysis technology developer IXICO is providing data analytics and neuroimaging services for a late phase clinical research programme in Huntingdon’s disease. 

This will generate revenues of £500,000. In the year to September 2018, group revenues were £5.39m. There was £7.86m in the bank at the end of September 2018.

IXICO has been chosen as a partner in the London Medical Imaging and Artificial Intelligence Centre for Value-Based Healthcare. The project is headed up by King’s College and it will develop AI algorithms from NHS medical images and patient data. This will help to speed up diagnosis. 

© 2019 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

News Blog
All micro news

Northern Bear

Roofing and building services provider Northern Bear directors say they will not accept the 72p a share tender offer from Cedarvale Holdings. 

Continue reading... | 21/10/2019

LiDCO Group

Patient monitoring devices supplier LiDCO increased its product revenues by 10% in the year to July 2019. 

Continue reading... | 21/10/2019

Quoted Micro 14 October 2019

Continue reading... | 14/10/2019

Hague and London Oil

Former Aim company Hague and London Oil reported a decline in revenues in the first half of 2019, but it moved from loss to profit, but this was due to a gain on derivative instruments. 

Continue reading... | 13/10/2019

All micro news

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at Subscribe to AIM Micro RSS Feeds